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Abstract
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The cell interior is a crowded chemical space, which limits the diffusion of molecules and
organelles within the cytoplasm, affecting the rates of chemical reactions. We provide insight into
the relationship between non-specific intracellular diffusion and cytoskeletal integrity. Quantum
dots entered the cell through microinjection and their spatial coordinates were captured by
tracking their fluorescence signature as they diffused within the cell cytoplasm. Particle tracking
revealed significant enhancement in the mobility of biocompatible quantum dots within
fibrosarcoma cells versus their healthy counterparts, fibroblasts, as well as in actin destabilized
fibroblasts versus untreated fibroblasts. Analyzing the displacement distributions provided insight
into how the heterogeneity of the cell cytoskeleton influences intracellular particle diffusion. We
demonstrate that intracellular diffusion of non-specific nanoparticles is enhanced by disrupting the
actin network, which has implications for drug delivery efficacy and trafficking.

Introduction

Author Manuscript

Actin and tubulin form highly versatile, dynamic polymers that are fundamental to creating
the spatial organization of eukaryotic cells through cytoskeletal structures. These
cytoskeletal systems are dynamic and adaptable, capable of organizing intracellular
compartments, and are critical to a number of cell processes including cell migration and
division. Inside these compartments is a crowded chemical space in which the volume
fraction of macromolecules can reach up to 40%.1 This large volume fraction limits
diffusion of molecules and organelles within the cytoplasm and therefore affects the rates of
chemical reactions in the cell. A contributor to this confinement is the cytoskeleton itself,
which features a mesh-like network with open spaces that direct the diffusion of
macromolecules. The structural role of the actin and microtubule network within cell
*
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Candidates for assessing intracellular trafficking include tracking small fluorescent
molecules using FRAP17 or FCS18, or tracking micron and sub micron particles using single
particle tracking (SPT)19 or extensions thereof.15 Particle mobility has also been studied as a
probe of local viscosity in the field of microrheology.20 Labeling a few molecules by
fluorescent dyes can achieve high temporal resolution but lack the lateral/spatial resolution
that SPT can achieve. SPT can be limited by photobleaching of fluorophores if used, and the
inability to track particles that travel perpendicular to the imaging plane. However, SPT has
been shown to be well suited to the study of living cell interiors.19, 21–25 Quantum dots
(QDs) present a unique opportunity for stable particle tracking as they are not subject to
photobleaching and can be synthesized to respond to a variety of chosen wavelengths as well
as include a chemically grafted outer shell either to confer, or to prevent, specific biological
interactions. SPT of QDs within the cellular environment has been used to investigate
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mechanics has been previously investigated2–4 and together with the whole cytoskeleton
network, cytoplasmic organelles, and molecular crowding, serves as obstacles to nondirected intracellular motion. Intracellular particle diffusion has become increasingly
important within nanomedicine, where nano-scale photodynamic therapies5–7 and gene or
drug delivery systems8–11 have made significant advances in disease treatment options. The
effect of the cytoskeleton on the diffusion of nanoparticles brings into question the relative
size scales between the mesh and the translocating objects. The actin network has been
reported to have a heterogeneous mesh size ranging from 30–100 nm (Luby-Phelps12) to
300–600 nm (Kusumi et al.13) across mammalian cells. More recently, Kronlage et al.14
measured the open pore size within the actin cytoskeleton of endothelial cells under control
conditions of approximately 10,000 nm2 (about 100 nm square) and under cytochalasin D
treatment, the open area increases to above 30,000 nm2 (173 nm square). When particle size
is similar to or greater than the cytoskeletal mesh, the resulting confinement allows for the
measuring of the microrheological properties of the cell interior.15, 16 Alternatively, particles
smaller than the mesh are subjected to a different microenvironment than larger particles.
The different local environment will affect the diffusivity of small particles, critical in
nanoparticle-based therapies or diagnostics. For example, in endosomal release of
theranostic nanomaterials (e.g., nanoparticle mediated siRNA delivery8, 9), particles must
translocate to an alternative intracellular site (e.g., the nucleus), where they accumulate for
efficacy of the therapy. To determine the potential for accumulation and therefore the
efficacy of these nanoparticle therapies, we must understand the dynamics involved in
intracellular nanoparticle diffusion. Here we discuss the influence of cytoskeletal integrity,
namely filamentous actin and microtubules, on intracellular nanoparticle diffusion
manifested in different cell conditions. Motivated by prior elasticity measurements,2 we
identify differences between two cell types, one cancer (fibrosarcoma cells HT 1080) and
one non-cancer (human dermal fibroblasts), as well as drug-altered cytoskeletons within
those two lines by cytochalasin D treatment (disrupts filamentous actin) and nocodazole
treatment (disrupts microtubules). Within the cytoplasm of these cells, the nanoparticles act
as internal probes that reflect the influence of the cytoskeleton and its caged network on
transport. Analysis of the nanoparticle paths further provides quantitative values of diffusion
coefficients that drug carrier and similarly sized biomaterials have inside healthy and
diseased cells.

Author Manuscript
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specific cellular processes such as insulin receptor activity,26 virus infection,27, 28 calcium
flux detection,29 and kinesin motor transport.30 Polymer coated nanoparticles have also been
used in treatment regimes such as targeted killing of tumor cells5, 6 and alleviating liver
damage.31 Once inside the cell, SPT has revealed dynamic properties of delivered particles.
Freely diffusive particles (Brownian motion) have a linear relationship between time and
mean square displacement (MSD), however, intracellular transport typically results in
subdiffusive or confined behavior, i.e., movement of particles with less than t1 dependence.4
The distinction between Brownian motion and subdiffusive motion in the cellular
environment is extremely important: if particles are confined, the time and even ability to
reach a desired intracellular destination will be affected. Identifying which cellular
components contribute to this confinement is critical to understanding intracellular transport.

Author Manuscript

Our results indicate that the diffusion of small, polymer-grafted QDs is sensitive to
cytoskeletal modifications, particularly actin network connectivity. Unlike preceding QD
intracellular tracking experiments32 these QDs have no specific affinity for binding within
the cell. The PEG coating on our QDs has been shown repeatedly to be the most highly noninteracting polymer coating for cellular environments.21, 33 We demonstrate that
heterogeneity in the actin network either manifested by cell type or by disruption of
cytoarchitecture within healthy cell types results in a change in nanoparticle dynamics thus
signifying that the cytoskeleton organization can act as a barrier for non-motor driven
intracellular trafficking.

Results and Discussion
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In our work, CdSe quantum dots (4 nm) were grafted with a biocompatible PEG34 brush
(Mw=5 kDa) that neither interacts with intracellular components nor is toxic to the cell. For
example, prior work shows that Ag nanoparticles are toxic to THP-1 cells resulting in a
change in cell viscoelasticity with a two fold increase in complex modulus.35 The PEG
grafted QDs have a hydrodynamic diameter of 10 nm, determined by diffusion in
glycerol:water with known viscosity (supplementary materials). QDs entered each cell by
microinjection using an Eppendorf Injection system (supplementary materials), which
provides a fast introduction (0.5 s) of QDs by pressure-driven injection of small liquid
volumes. The micropipettes had an outer diameter of 1 μm. The delivery and diffusion of
QDs were monitored throughout the cell cytoplasm. We manipulated the needle by using a
common piezoelectric micromanipulator integrated with a Nikon inverted epifluorescence
microscope with 100× oil-immersion objective. The needle was manipulated to approach
and penetrate the cell at an angle of 30 degrees from the surface plane. During QD delivery,
we could precisely locate the needle in the cellular environment in brightfield and
fluorescence imaging mode. The photo stability of QDs allowed continuous observation of
QDs for the duration of video capture, which was between 5 and 10 minutes.
To quantify the QD dynamics, we carried out SPT using free software to connect particle
centers of mass across images, obtaining particle trajectories.36 Figure 1a–c includes a
subset of 50 particle trajectories from QDs in the cytoplasm of fibroblasts, fibrosarcoma
cells, and cytochalasin D treated fibroblasts as well as an overlay of all 699, 634, and 353
trajectories, respectively.
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The QDs within the fibrosarcoma cell cytoplasm had greater mobility than within the
fibroblast possibly because the cytoskeletal network is more disorganized. For example, in
model mouse ovarian cancer cells, in addition to changes in gene expression levels, the
cytoskeleton structure became increasingly disorganized during neoplastic progression.37
Other reports confirm the deformation capacity of cancer cells (and metastatic potential) is
due to differences in the cytoskeleton and nuclear protein organization.38–42

Author Manuscript

To test if the particular organization of microfilaments within the fibrosarcoma cell line
contributed to a change in the mobility of the QDs, cytochalasin D was used to disrupt the
filamentous actin network in fibroblasts to achieve less organization. This treatment resulted
in a longer mean free path of the QD consistent with the comparison between fibroblasts and
fibrosarcoma cells (see supplementary materials for actin staining). We also investigated
how QD diffusion was influenced by the breakdown of the microtubule network induced by
nocodazole treatment. We found that the mobility of QDs within fibroblasts was less
affected by nocodazole treatment than cytochalasin D treatement, which is consistent with
prior studies showing that the mechanical properties of fibroblasts do not change
significantly when exposed to nocodazole.2 From the particle tracks, MSD was determined
using MATLAB43. MSDs for QDs within fibroblasts, fibrosarcoma cells, and cytochalasin D
treated fibroblasts are shown in Figure 1d–f respectively. To compare ensemble differences,
we analyzed the particle trajectories using (1) the center of the MSD distributions at a range
of delay times to compare overall mobility, (2) a power law fit to the data to extract diffusion
parameters, and (3) step sizes at particular temporal windows to probe local dynamic
heterogeneity.

Author Manuscript

At a delay time of 1 s, Figure 2 shows the MSD for QDs in fibroblasts, fibrosarcoma cells,
and fibroblasts treated with cytochalasin D. Although the MSD has a broad distribution in all
cases, QDs within the fibrosarcoma cell cytoplasm travel the furthest with a MSD geometric
average near 6 × 104 nm2 compared to the fibroblast case centered near 6 × 103 nm2. After
exposing fibroblasts to cytochalasin D, the MSD values broadened and the geometric center
value increased to 3 × 104 nm2 an order of magnitude increase over the fibroblast case and
only 50% less than the fibrosarcoma cell value. These relationships persist at shorter and
longer delay times, namely t = 0.5 s and 3 s. For fibroblasts, the breadth and number of
tracks with MSDs greater than 104 nm2 significantly increased upon exposure to
cytochalasin D suggesting an increase in mobility and less confinement of QDs during
diffusion. Interestingly, MSD values for fibroblasts and cytochalasin D treatment correspond
to the open spaces within the actin network measured by Kronalge14 within endothelial
cells.
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As demonstrated by previous particle dynamics researchers, particles within cells tended
toward subdiffusive rather than Brownian motion with a few exceptions.4 The MSD for
diffusion can be given by MSD = 2Dtα where D is the diffusion coefficient, t is time, and α
is the power law exponent. A power law was fit to each condition and sorted for those
trajectories with r2 values greater than 0.7 (43% of trajectories within fibroblasts and 72% of
trajectories within fibrosarcoma cells fit this criteria). For QDs diffusing in fibrosarcoma
cells, the power law exponents centered around 0.75 whereas for fibroblasts, alpha was
lower, centered around 0.60 as shown in Figure 3. Thus, QDs within the cytoplasm of
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fibrosarcoma cells experienced less confinement. When the actin network of fibroblasts was
disrupted using cytochalasin D, decreasing network confinement, the power law exponent
increased to 0.70 representing a shift toward Brownian motion but still exhibiting subdiffusive behaviour. Alternatively, when the actin network of fibrosarcoma cells was
disrupted, power law exponents for QDs within fibrosarcoma cells were minimally affected
by cytochalasin D treatment (supplementary materials). Diffusion coefficients were
determined from tracks with alphas between 0.75 and 1.25. The percentage of tracks that fall
into this range are 12% and 33% for fibroblasts and fibrosarcoma cells, respectively. For
QDs within fibroblasts, the diffusion coefficient was 4 × 104 nm2/s, whereas QD diffusion
was twice as high in fibrosarcoma cells, 9 × 104 nm2/s.
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Destabilizing the actin of the fibroblasts increased the diffusion coefficient to 13 × 104
nm2/s, which is three times higher than in the control cells and larger than fibrosarcoma
cells. These diffusion coefficients are smaller than expected for QD diffusion in water, (the
main solvent of the cytosol) which is attributed to obstacles such as organelles and
cytoskeletal network in the cytoplasm12. A significant finding of this study is that small
particles move faster and further upon disrupting the actin cytoskeletal network. While
diffusion coefficients are extracted from particles that followed Brownian motion, these
parameters represent a smaller subset of the particles. Most particles experienced confined
motion and a more detailed analysis of particle step size provides further insight into the
overall response of QDs to the cell cytoplasm.
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The distribution of QD displacements provides further insight into the nanoscale
environment and dynamic heterogeneity experienced by the QDs. The van Hove correlation
function, Δ, describes the probability of a particle moving a distance along a single axis
within a specific time interval, τ.44 The self-portion, the average motion of the particle
initially at the origin, is given by Δ=x(t+τ)−x(t) and y(t+τ) −y(t) for steps in the × and y
directions, respectively.45 The van Hove distributions were calculated using the above
equation for Δ and normalizing the area under the curves to one. The van Hove distributions
for fibroblast, fibroblast cells exposed to cytochalasin D, fibrosarcoma cells, and
glycerol:water are displayed in Figure 4. The van Hove distribution is Gaussian for spatially
homogenous environments46 and was observed for QDs within homogeneous glycerol:water
solutions (Figure 4d). While all cell distributions (Figure 4a–c) clearly deviate from
Gaussian and exhibit central peaks at all time intervals, the larger displacement tails are
qualitatively and quantitatively different. As seen by the area under the displacement
distribution in Figure 4a, the majority of QDs within fibroblast cells were confined to
displacements of 200 nm, while larger displacements had a low likelihood of occurring.
Additionally, displacements larger than 1000 nm were not realized in fibroblast cells at a
time interval of 1 s. The limited time dependence, evidenced by the nearly overlapping
values at all time intervals, indicates QDs in fibroblast cells were exploring a confined
spatial region. Displacement distributions of QDs within fibroblast cells exposed to
cytochalasin D display a greater likelihood of large displacements, as seen by the increased
area under the curve in Figure 4c. The distributions display an increasing range of motion
with increasing time from 0.12 to 0.6 s, indicating that the QDs explored a greater spatial
area. A smaller change is seen from 0.6 to 1 s, commensurate with the MSD and alpha
distributions, which display greater, but still confined, QD mobility. Similar behavior is seen
Soft Matter. Author manuscript; available in PMC 2018 March 01.
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for QDs within the fibrosarcoma cells, Figure 4b. QD displacements were larger, even at
0.12 s, than QD displacements within fibroblast cells. While the central Gaussian peaks
correspond to displacements bounded by approximately ±200 nm for all conditions, the tails
of the distribution exhibit an exponential dependence that can be quantified by characteristic
lengths, Table 1. Studies on particle dynamics in F-actin solutions47 have established that the
exponential tails reflect the interaction between particle and environment. For our study,
these length scales indicate the degree of confinement of QDs by their local environment.
The characteristic lengths of the QD displacement distribution tails within fibroblasts
changed negligibly with increasing time, from 96 nm to 115 nm at time intervals of 0.12 s
and 1 s, respectively. For fibroblast cells exposed to cytochalasin D, however, the
characteristic length increased from 193 to 328 nm from 0.12 to 1 s. Fibrosarcoma cells
show an increase in characteristic length from 130 to 224 nm over the same time interval.
The characteristic length of the fibrosarcoma cells exposed to nocodazole decreased to 98
nm and 140 nm from control values of 130 nm and 224 nm, respectively at time intervals of
0.12 and 1 s corresponding to a decrease in mobility (Supplementary Material). The
displacement distributions and characteristic lengths of QDs within fibroblast cells exposed
to nocodazole and QDs within fibrosarcoma cells exposed cytochalasin D, display behaviors
similar to their control condition (Supplementary Material).

Author Manuscript
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The differences observed in the displacement distributions can be explained by changes in
the nanoscale environment the QDs experience. In fibroblasts, QDs were confined by the
actin network, which is heterogeneous, yet has a mesh dimension on the order of 400 nm
consistent with the central peak of the distribution, ±200 nm, that confines the majority of
the QD displacements. Studies on nanoparticle mobility within gels48 have used the central
Gaussian portion of the van Hove to characterize caging lengths. In the case of QDs within
the cell cytoplasm, we assert that the relevant caging length scale is the average mesh size.
In fibroblasts, escaping a primary mesh and traveling to a neighbouring mesh is a rare event,
resulting in a drastically different environment experienced by the QD. In comparison to
published research on the mesh size of the actin network, values of 100–200 nm12,14 are
more prevalent than values of 300–600 nm13 for fibroblast cell lines. The actin mesh size is
cell type dependent as well as locally heterogeneous as the network undergoes densification
toward the cell periphery. Our experiments avoid the cell periphery and thus would expect a
slightly larger mesh size as a result. In fibroblasts exposed to cytochalasin D, the actin
network was disrupted (supplementary materials). While a primary mesh of 400 nm exists in
some areas demonstrated by the van Hove distribution width, the connectivity of the network
has decreased, homogenizing the distribution of mesh sizes. This loss of connectivity
increases the probability of QDs moving between primary meshes, allows QDs to explore
more area with increasing time, and decreases the confinement experienced by QDs within
the cytoplasm, ultimately leading to increased QD mobility. In fibrosarcoma cells, the
disorganized actin cytoskeleton (supplementary materials) allows QDs to move between
primary meshes, to explore more area with increasing time, and to experience less
confinement from the actin cytoskeleton. These disparate dynamic behaviors of
nanoparticles in different cell lines and conditions indicate differences in the local
microenvironment.
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The use of nanoparticles as probes to understand complex environments spans many fields,
from industrially relevant polymer gels to extracellular polymer networks.49, 50 Additionally,
non-Gaussian dynamics, specifically displacement distributions with exponentially decaying
tails, have been observed in a wide variety of nano and micron scale systems, such as
colloidal suspensions,51 solutions of f-actin,47 and recently, live muscle cell membranes.11
Our study shows nanoparticles within the cell cytoplasm also move in a non-Gaussian
manner, indicating the ubiquitous nature of non-Gaussian dynamics and calling for enhanced
models to determine diffusion properties when Gaussian relationships do not hold. Also, the
dynamic behavior of QDs provided spatial information about the altered cytoskeletal
networks, including average mesh size and changes in the mesh hindrance.

Author Manuscript

Geometric mean MSDs are shown in Figure 5 for all QD particle tracks within this study,
which summarizes QD diffusion within each cell line and drug condition. The geometric
mean was chosen to represent the central tendency because the distribution of values did not
follow a standard normal distribution. QDs within fibroblasts and fibroblasts treated with
nocodazole (microtubule disruption) exhibited the lowest MSDs. Disrupting the actin
network with cytochalasin D treatment resulted in a significant increase (order of
magnitude) in MSD whose behavior becomes similar to the fibrosarcoma results. Disruption
of the cytoskeletal elements within fibrosarcoma cells with either nocodazole or cytochalasin
D resulted in a decrease in MSD. QD mobility increased by an order of magnitude within
fibrosarcoma cell cytoplasm compared to within the fibroblast cytoplasm.

Author Manuscript

Altering the connectivity of the actin network within fibroblasts resulted in QD mobility
similar to that of QDs within the untreated fibrosarcoma cell cytoplasm. The intrinsic
differences between the two cell lines result in vastly different intracellular particle mobility.
What this research demonstrates is the sensitivity of intracellular QD diffusion to actin
cytoskeletal modifications. Not all cytoskeletal modifications had equal effects, as
nocodazole treatment, which attacks the microtubule network, had little effect on the MSD
of QDs within the fibroblast cytoplasm. Interestingly, actin and microtubule disruption of
fibrosarcoma cells resulted in slightly decreased mobility of QDs within the cytoplasm. One
possibility is that the local microviscosity of the fibrosarcoma cells experience a greater
change in response to the toxins than the fibroblasts. Measures of elasticity of the same cell
lines indicated a stiffening behavior in the fibrosarcoma line in response to microtubule
disruption.2

Experimental Methods
Cell culture

Author Manuscript

Human dermal fibroblasts and HT 1080 (fibrosarcoma cells). Fibroblasts were cultured in
Fibrolife (Lifeline Cell Technologies) were cultured for this study. All cells were incubated
at 37 °C in a humidified atmosphere with 5% CO2. Dishes and coverslips were coated for
30–40 min with 5 μg/mL fibronectin (BD Biosciences) dissolved in PBS prior to plating.
Cells were initially plated at 75–100k density on glass coverslips (22 × 40 mm) for all
studies, and were incubated for 48 hrs prior to experiments. Three conditions were studied:
control (recording buffer only), 2.5 μM Cytochalasin D (Sigma Aldrich) in recording buffer
for 30 min, and 10 μM Nocodazole (Sigma Aldrich) in recording buffer for 30 min.
Soft Matter. Author manuscript; available in PMC 2018 March 01.
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A Nikon Eclipse Ti inverted fluorescence microscope was paired with an Eppendorf
InjectMan4 micromanipulator and Eppendorf FemtoJet4i pressure injector. QDs were
dispersed in DI water at 0.2 nM concentration and loaded into Eppendorf Femtotips. Typical
input pressure values used were 200–400 hPa. Injections lasted 0.5 to 1 s. An x–y stage
mounted to the microscope platform allowed the movement of the cell-coated coverslip into
different viewing windows.
Particle tracking

Author Manuscript

Videos were recorded in brightfield before injection, then fluorescence just after injection,
and finally brightfield again to examine the cell. Particle tracking software, FIESTA, was
used to extract particle tracks from the fluorescence signature of QDs within the recorded
videos. A frame rate of 16.9 fps was used and the calibration of the objective was 110 nm
per pixel. The FIESTA program applies a Gaussian fit to the fluorescence to determine the
center of the fluorescence with nm precision. A selection box was used to identify
approximate cell boundaries and to limit the run time of the program by excluding areas
outside of the cell from analysis. Drift was evaluated using immobilized QDs and found to
be on the order of error in positioning. Particle tracks with an average positioning error
greater than 25 nm were excluded from analysis.
Conclusions
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Although our method could be employed to observe a variety of dynamic biological events,
we have placed an emphasis on evaluating the effect of the cytoskeletal network on nondirected diffusion as opposed to active motor-driven transport. We have compared fibroblasts
and fibrosarcoma cells with two cytoskeletal destabilizers acting on distinct elements. The
results indicate that non-specific transport of nanoscale particles is inhibited by confinement
due to the actin network. This is an intriguing phenomena brought on by small size scales;
the nanoscale particles are affected by a mesoscale network, which shifted nanoparticle
mobility toward subdiffusive, non-Gaussian dynamics more than would be expected simply
due to the viscous material present between the mesh. In our work, the influence of
intermediate filaments has not been explored. According to Guo et al.,52 intermediate
filaments may play a role in intracellular dispersion of larger organelles within cells.
Specifically, the tracking of endogenous vesicles within mouse embryonic fibroblasts
revealed increased motility in cells that lack vimentin intermediate filaments. We anticipate
further studies to elucidate the effects of intermediate filaments on small particle transport.
Further extensions of our work include probing the effects of bridging proteins (e.g., plectin,
septins, myosin filaments), DNA linking, motor driven transport, and implications for
understanding nanoparticle trafficking and therapeutics in diseased cells. Specifically, many
anti-cancer drugs target the destabilization of filamentous actin and microtubule spindle
dynamics.10 From our study, anti-cancer drugs that disrupt the cell architecture would not
greatly affect the dynamics of nanoparticle drug carriers within cancerous cells, but would
increase transport of the nanoparticles within the surrounding healthy tissues should the drug
carriers also enter these cells. In conclusion, we have demonstrated that the relationship
between nanoparticle dynamics and cytoskeletal integrity is of critical importance to
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particles smaller than the mesh size, which leads to changes in confinement, diffusion
parameters, and even the ability of a nanoparticle to reach a desired intracellular destination.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

Individual QD particle trajectories (50) within (a) fibroblasts, (b) fibrosarcoma cells, and (c)
fibroblasts with cytochalasin D treatment with overlay insets where trajectories are
initialized at (0,0) and include all 699, 634, and 353 trajectories recorded, respectively. Mean
squared displacements (MSD) of QDs within (d) fibroblasts, (e) fibrosarcoma cells and (f)
fibroblasts with cytochalasin D treatment. Color scale used to indicate higher MSD is carried
through for individual particle tracks in (a–c).
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Figure 2.

Histogram of log of MSDs at a delay time of 1 s for QDs within (a) fibroblasts, (b)
fibrosarcoma cells, and (c) fibroblasts with cytochalasin D treatment.
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Figure 3.

Histogram of power law diffusion exponent, α, for QDs within control fibroblasts (Fibro,
blue solid), fibrosarcoma cells (Fsarcoma, red), and fibroblasts with cytochalasin D
treatment (Fibro+Cyto, blue hash). Distribution centers are noted with vertical lines for each
distribution.
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Figure 4.

van Hove distributions for QDs within (a) fibroblasts, (b) fibrosarcoma cells, (c) fibroblasts
with cytochalasin D treatment, and (d) 90% glycerol:water solution at three time increments
of 0.12 s, 0.6 s, and 1 s. Step size, Δ, combines steps in both × and y into a single van Hove
distribution.
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Figure 5.

Geometric mean MSD for each of six conditions. Nomenclature is as follows: fibrosarcoma
cells (FSarcoma), fibroblasts (Fibro), cytochalasin D treatment (Cyto), nocodazole treatment
(Noco). Error bars are standard error.
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Author Manuscript

Characteristic lengths extracted from van Hove distributions for fibroblasts (Fibro), fibrosarcoma cells
(FSarcoma), and fibroblasts treated with cytochalasin D (Fibro+Cyto).
Cell Type

Fibro

FSarcoma

Fibro+Cyto

Author Manuscript

Time (s)

Characteristic Length (nm)

0.12

96.0

0.6

101.2

1.0

114.9

0.12

129.4

0.6

187.0

1.0

224.4

0.12

192.9

0.6

297.6

1.0

328.4

Author Manuscript
Author Manuscript
Soft Matter. Author manuscript; available in PMC 2018 March 01.

